Literature DB >> 1760816

Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients.

K Jhaver1, A De, S Advani, J Nadkarni.   

Abstract

Peripheral blood monocytes from non-Hodgkin's lymphoma (NHL) patients were assessed for the monocyte functions with respect to their ability to secrete interleukin-1 and tumour necrosis factor (TNF) and their cytotoxic potential to tumour target WEHI 164 clone 13. Our results indicate comparable levels of interleukin-1 and TNF production by NHL patients. The cytotoxic potential by monocytes was also not depressed in these patients. The data obtained suggest normal monocyte functions in NHL patients.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1760816     DOI： 10.1007/bf01741346

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


  26 in total

1.  Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.

Authors:  B A Metha; S H Advani; S J Nadkarni
Journal:  Neoplasma       Date:  1988       Impact factor: 2.575

2.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

4.  Impaired production of tumor necrosis factor in breast cancer.

Authors:  C C Zielinski; C Mueller; E Tyl; E Tichatschek; E Kubista; J Spona
Journal:  Cancer       Date:  1990-11-01       Impact factor: 6.860

5.  Impairment of monocyte functions in advanced head and neck cancer.

Authors:  O Garraud; A Faucher; E Legrand
Journal:  Immunol Lett       Date:  1988-07       Impact factor: 3.685

6.  Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.

Authors:  R S Kornbluth; T S Edgington
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

Review 7.  An update on human interleukin-1: from molecular biology to clinical relevance.

Authors:  C A Dinarello
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

8.  Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.

Authors:  J Nissen-Meyer; E Hofsli; T Espevik; R Austgulen
Journal:  Nat Immun Cell Growth Regul       Date:  1988

9.  Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity.

Authors:  H W Ziegler-Heitbrock; C Thiel; J G Haas; A Möller; G Riethmüller
Journal:  Nat Immun Cell Growth Regul       Date:  1988

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.